Federal Insurance PLC (DSE:FEDERALINS)
Bangladesh · Delayed Price · Currency is BDT 20.50
-0.30 (-1.44%)
At close: Aug 11, 2025
SpringWorks Therapeutics Income Statement
Financials in millions BDT. Fiscal year is January - December.
Millions BDT. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Premiums & Annuity Revenue | 391.13 | 379.95 | 393.55 | 372.2 | 369.83 | 335.71 | Upgrade |
Total Interest & Dividend Income | 26.56 | 27.45 | 30.59 | 24.71 | 22.11 | 25.2 | Upgrade |
Gain (Loss) on Sale of Investments | -3.25 | -3.25 | 0.41 | 4.15 | 10.96 | 7.88 | Upgrade |
Other Revenue | 69.29 | 68.85 | 71.16 | 81.69 | 68.58 | 79.27 | Upgrade |
| 485.09 | 474.36 | 495.7 | 482.75 | 471.49 | 448.07 | Upgrade | |
Revenue Growth (YoY) | 0.94% | -4.31% | 2.68% | 2.39% | 5.23% | 2.52% | Upgrade |
Policy Benefits | 82 | 74.68 | 96.4 | 90.16 | 91.79 | 52.23 | Upgrade |
Policy Acquisition & Underwriting Costs | 83.77 | 82.05 | 84.32 | 87.36 | 40.49 | 77.09 | Upgrade |
Depreciation & Amortization | 19.2 | 19.16 | 20.97 | 22.95 | 22.04 | 17.5 | Upgrade |
Selling, General & Administrative | 169.46 | 168.81 | 168.68 | 160.5 | 170.05 | 160.56 | Upgrade |
Provision for Bad Debts | 5 | 5 | 5 | 3 | 3 | 3 | Upgrade |
Reinsurance Income or Expense | -0.01 | -0.01 | -0.01 | -0.02 | -0.03 | -0.1 | Upgrade |
Total Operating Expenses | 365.35 | 355.63 | 381.07 | 369.59 | 334.4 | 317.23 | Upgrade |
Operating Income | 119.73 | 118.73 | 114.63 | 113.16 | 137.08 | 130.84 | Upgrade |
Interest Expense | -0.56 | -0.56 | -0.68 | -0.95 | -0.91 | -2.63 | Upgrade |
Other Non Operating Income (Expenses) | 0 | 0 | 0 | 0 | 0 | - | Upgrade |
EBT Excluding Unusual Items | 119.17 | 118.17 | 113.95 | 112.21 | 136.18 | 128.21 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 3.88 | - | Upgrade |
Pretax Income | 119.17 | 118.17 | 113.95 | 112.21 | 140.06 | 128.21 | Upgrade |
Income Tax Expense | 46.75 | 46.37 | 45.75 | 38.74 | 43.7 | 38.21 | Upgrade |
Net Income | 72.42 | 71.79 | 68.2 | 73.48 | 96.36 | 90 | Upgrade |
Net Income to Common | 72.42 | 71.79 | 68.2 | 73.48 | 96.36 | 90 | Upgrade |
Net Income Growth | 8.33% | 5.27% | -7.18% | -23.75% | 7.07% | 97.69% | Upgrade |
Shares Outstanding (Basic) | 71 | 71 | 71 | 71 | 71 | 71 | Upgrade |
Shares Outstanding (Diluted) | 71 | 71 | 71 | 71 | 71 | 71 | Upgrade |
EPS (Basic) | 1.02 | 1.01 | 0.96 | 1.03 | 1.36 | 1.27 | Upgrade |
EPS (Diluted) | 1.02 | 1.01 | 0.96 | 1.03 | 1.36 | 1.27 | Upgrade |
EPS Growth | 8.33% | 5.27% | -7.18% | -23.75% | 7.07% | 97.69% | Upgrade |
Free Cash Flow | -3.84 | -26.89 | 47.62 | 93.78 | 175.01 | 145.99 | Upgrade |
Free Cash Flow Per Share | -0.05 | -0.38 | 0.67 | 1.32 | 2.46 | 2.06 | Upgrade |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 0.476 | Upgrade |
Dividend Growth | - | - | - | - | 110.00% | - | Upgrade |
Operating Margin | 24.68% | 25.03% | 23.13% | 23.44% | 29.07% | 29.20% | Upgrade |
Profit Margin | 14.93% | 15.14% | 13.76% | 15.22% | 20.44% | 20.09% | Upgrade |
Free Cash Flow Margin | -0.79% | -5.67% | 9.61% | 19.43% | 37.12% | 32.58% | Upgrade |
EBITDA | 133.82 | 132.77 | 129.42 | 128.97 | 142.26 | 139.76 | Upgrade |
EBITDA Margin | 27.59% | 27.99% | 26.11% | 26.72% | 30.17% | 31.19% | Upgrade |
D&A For EBITDA | 14.08 | 14.04 | 14.79 | 15.81 | 5.18 | 8.92 | Upgrade |
EBIT | 119.73 | 118.73 | 114.63 | 113.16 | 137.08 | 130.84 | Upgrade |
EBIT Margin | 24.68% | 25.03% | 23.13% | 23.44% | 29.07% | 29.20% | Upgrade |
Effective Tax Rate | 39.23% | 39.24% | 40.15% | 34.52% | 31.20% | 29.80% | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.